Induction of VEGFA mRNA translation by CoCl2 mediated by HuR

RNA Biology

Volumn 12, Issue 10, 2015, Pages 1121-1130

  Osera, Cecilia ^a,b   Martindale, Jennifer L ^a   Amadio, Marialaura ^b   Kim, Jiyoung ^a   Yang, Xiaoling ^a   Moad, Christopher A ^a   Indig, Fred E ^a   Govoni, Stefano ^b   Abdelmohsen, Kotb ^a   Gorospe, Myriam ^a   Pascale, Alessia ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Biotin pulldown; Mass spectrometry; Polysome profiling; Post transcriptional gene regulation; Ribonucleoprotein complex; RNA binding proteins

Indexed keywords

COBALT CHLORIDE; ELAV LIKE PROTEIN 1; MESSENGER RNA; PROTEIN; RNA BINDING PROTEIN; VASCULOTROPIN A; COBALT; ELAVL1 PROTEIN, HUMAN; RIBONUCLEOPROTEIN; VEGFA PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BIOTIN PULLDOWN ANALYSIS; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; INVESTIGATIVE PROCEDURES; MASS SPECTROMETRY; MEDIATOR RELEASE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN SECRETION; RNA STABILITY; RNA TRANSLATION; BIOSYNTHESIS; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS;

CELL HYPOXIA; COBALT; ELAV-LIKE PROTEIN 1; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MASS SPECTROMETRY; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBONUCLEOPROTEINS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84954521965     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2015.1085276     Document Type: Article

References (50)

1. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550-63; PMID: 15664381; http:// dx. doi. org/10. 1016/j. cardiores. 2004. 12. 002
2. Arcondéguy T, Lacazette E, Millevoi S, Prats H, Touriol C. VEGF-A mRNAprocessing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res 2013; 41: 7997-8010; http://dx. doi. org/ 10. 1093/nar/gkt539
3. Eswarappa SM, Potdar AA, Koch WJ, Fan Y, Vasu K, Lindner D, Willard B, Graham LM, DiCorleto PE, Fox PL. Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell 2014; 157: 1605-18; PMID: 24949972; http://dx. doi. org/10. 1016/j. cell. 2014. 04. 033
4. Pages G, Pouyssegur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc Res 2005; 65: 564-73; PMID: 15664382; http://dx. doi. org/10. 1016/j. cardiores. 2004. 09. 032
5. Kurihara T, Westenskow PD, Friedlander M. Hypoxiainducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina. Exp Med Biol 2014; 801: 275-81; http://dx. doi. org/10. 1007/978-1-4614-3209-8_35
6. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 633-60; PMID: 12778148; http://dx. doi. org/10. 1038/nm0603-653
7. Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 2006; 90: 1542-7; PMID: 17114590; http://dx. doi. org/10. 1136/bjo. 2006. 098426
8. Michael IP, Westenskow PD, Hacibekiroglu S, Greenwald AC, Ballios BG, Kurihara T, Li Z, Warren CM, Zhang P, Aguilar E, et al. Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye. EMBO Mol Med 2014; 6: 604-23; PMID: 24705878
9. Ellis LM. Bevacizumab. Nat Rev Drug Discov 2005; S8-S9; PMID: 15962523; http://dx. doi. org/10. 1038/ nrd1727
10. Yao P, Potdar AA, Ray PS, Eswarappa SM, Flagg AC, Willard B, Fox PL. The HILDA complex coordinates a conditional switch in the 30-untranslated region of the VEGFA mRNA. PLoS Biol 2013; 11: e1001635; PMID: 23976881; http://dx. doi. org/10. 1371/journal. pbio. 1001635
11. Gerstberger S, Hafner M, Ascano M, Tuschl T. Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol 2014; 825: 1-55; PMID: 25201102; http://dx. doi. org/10. 1007/978-1-4939-1221-6_1
12. Srikantan S, Gorospe M. HuR function in disease. Front Biosci 2012; 17: 189-205; http://dx. doi. org/ 10. 2741/3921
13. Pascale A, Govoni S. The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNAbinding proteins. Cell Mol Life Sci 2012; 69: 501-17; PMID: 21909784; http://dx. doi. org/10. 1007/s00018-011-0810-7
14. Bolognani F, Perrone-Bizzozero NI. RNA-protein interactions and control of mRNA stability in neurons. J Neurosci 2008; 86: 481-9
15. Govindaraju S, Lee BS. Adaptive and maladaptive expression of the mRNA regulatory protein HuR. World J Biol Chem 2013; 4: 111-8; PMID: 24340134
16. Amadio M, Scapagnini G, Lupo G, Drago F, Govoni S, Pascale A. PKCbetaII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. Pharmacol Res 2008; 57: 60-6; PMID: 18206386; http://dx. doi. org/10. 1016/j. phrs. 2007. 11. 006
17. Galbán S, Kuwano Y, Pullmann R Jr, Martindale JL, Kim HH, Lal A, Abdelmohsen K, Yang X, Dang Y, Liu JO, et al. RNA-binding proteinsHuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol 2008; 28: 93-107; http://dx. doi. org/10. 1128/MCB. 00973-07
18. Milani P, Amadio M, Laforenza U, Dell'Orco M, Diamanti L, Sardone V, Gagliardi S, Govoni S, Ceroni M, Pascale A, et al. Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS. Neurobiol Dis 2013; 60: 51-60; PMID: 23969235; http://dx. doi. org/ 10. 1016/j. nbd. 2013. 08. 005
19. Amadio M, Scapagnini G, Davinelli S, Calabrese V, Govoni S, Pascale A. Involvement of ELAV RNA-binding proteins in the post-transcriptional regulation of HO-1. Front Cell Neurosci 2015; 8: 459; PMID: 25642166; http://dx. doi. org/10. 3389/fncel. 2014. 00459
20. Viiri J, Amadio M, Marchesi N, Hyttinen JM, Kivinen N, Sironen R, Rilla K, Akhtar S, Provenzani A, D'Agostino VG, et al. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/ p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS One 2013; 8: e69563; PMID: 23922739; http://dx. doi. org/10. 1371/journal. pone. 0069563
21. Amadio M, Bucolo C, Leggio GM, Drago F, Govoni S, Pascale A. The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol 2010; 80: 1230-7; PMID: 20599775; http://dx. doi. org/10. 1016/j. bcp. 2010. 06. 033
22. Amadio M, Osera C, Lupo G, Motta C, Drago F, Govoni S, Pascale A. Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model. Mol Vis 2012; 18: 2153-64; PMID: 22879735
23. Park H, Lee DS, Yim MJ, Choi YH, Park S, Seo SK, Choi JS, Jang WH, Yea SS, Park WS, et al. Three, 30-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-kB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions. Int J Mol Med 2015; [Epub ahead of print]; 36 (1): 301-8
24. Piret JP, Mottet D, Raes M, Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 2002; 973: 443-7; PMID: 12485908; http://dx. doi. org/10. 1111/j. 1749-6632. 2002. tb04680. x
25. Tominaga K, Srikantan S, Lee EK, Subaran SS, Martindale JL, Abdelmohsen K, Gorospe M. Competitive regulation of nucleolin expression by HuR and miR-494. Mol Cell Biol 2011; 31: 4219-31; PMID: 21859890; http://dx. doi. org/10. 1128/MCB. 05955-11
26. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M. miR-519 reduces cell proliferation by lowering RNAbinding protein HuR levels. Proc Natl Acad Sci U S A 2008; 105: 20297-302; PMID: 19088191; http://dx. doi. org/10. 1073/pnas. 0809376106
27. Zhou S, Gu L, He J, Zhang H, Zhou M. MDM2 regulates vascular endothelial growth factor mRNA stabilization in hypoxia. Mol Cell Biol 2011; 31: 4928-37; PMID: 21986500; http://dx. doi. org/10. 1128/MCB. 06085-11
28. Lebedeva S, Jens M, Theil K, Schwanhäusser B, Selbach M, Landthaler M, Rajewsky N. Transcriptomewide analysis of regulatory interactions of the RNAbinding protein HuR. Mol Cell 2011; 43: 340-52; PMID: 21723171; http://dx. doi. org/10. 1016/j. molcel. 2011. 06. 008
29. Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, Kulshrestha R, Panchakshari R, Kim HH, Yang X, et al. Translational control of TOP2A influences doxorubicin efficacy. Mol Cell Biol 2011; 31: 3790-801; PMID: 21768308; http://dx. doi. org/10. 1128/MCB. 05639-11
30. YancopoulosGD, Davis S, GaleNW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-8; PMID: 11001067; http://dx. doi. org/10. 1038/35025215
31. Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, Hooks JJ, Detrick B. Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration. Aging Dis 2014; 5: 88-100; PMID: 24729934
32. Zhou H, Chen X, Zhang WM, Zhu LP, Cheng L. HIF-1α inhibition reduces nasal inflammation in a murine allergic rhinitis model. PLoS One 2012; 7: e48618; PMID: 23133644; http://dx. doi. org/10. 1371/ journal. pone. 0048618
33. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol 1999; 83: 834-7; PMID: 10381671; http://dx. doi. org/10. 1136/bjo. 83. 7. 834
34. Penel N, Ray-Coquard I, Bal-Mahieu C, Chevreau C, Le Cesne A, Italiano A, Bompas E, Clisant S, Baldeyrou B, Lansiaux A, et al. Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial. Target Oncol 2014; 9: 273-7; PMID: 24218035; http://dx. doi. org/10. 1007/ s11523-013-0299-0
35. Briani C, Dalla Torre C, Lessi F, Cavallaro T, Scarlato M, Ferrari S, Campagnolo M, Lucchetta M, Cabrini I, Morbin M, et al. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study. J Neuroimmunol 2014; 277: 189-92; PMID: 25447599; http://dx. doi. org/10. 1016/j. jneuroim. 2014. 09. 021
36. Mahdy RA, Nada WM, Hadhoud KM, El-Tarhony SA. The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye 2010; 24: 1576-84; PMID: 20508651; http://dx. doi. org/10. 1038/eye. 2010. 86
37. Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia. Haematologica 1999; 84: 208-11; PMID: 10189383
38. Ruige JB, Bekaert M, Lapauw B, Fiers T, Lehr S, Hartwig S, Herzfeld de Wiza D, Schiller M, Passlack W, Van Nieuwenhove Y, et al. Sex steroid-induced changes in circulating monocyte chemoattractant protein-1 levels may contribute to metabolic dysfunction in obese men. J Clin Endocrinol Metab 2012; 97: E1187-91; PMID: 22523336; http://dx. doi. org/10. 1210/jc. 2011-3069
39. Ray PS, Jia J, Yao P, Majumder M, Hatzoglou M, Fox PL. A stress-responsive RNA switch regulates VEGFA expression. Nature 2009; 457: 915-9; PMID: 19098893; http://dx. doi. org/10. 1038/ nature07598
40. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, Ascano M Jr, Tuschl T, Ohler U, Keene JD. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell. 2011; 43: 327-39; PMID: 21723170; http://dx. doi. org/10. 1016/j. molcel. 2011. 06. 007
41. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995; 270: 13333-40; PMID: 7768934; http://dx. doi. org/ 10. 1074/jbc. 270. 22. 13333
42. Lu L, Wang S, Zheng L, Li X, Suswam EA, Zhang X, Wheeler CG, Nabors LB, Filippova N, King PH. Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J Biol Chem 2009; 284: 33989-98; PMID: 19805546; http://dx. doi. org/10. 1074/jbc. M109. 067918
43. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol 2008; 28: 772-83; PMID: 18039850; http://dx. doi. org/10. 1128/MCB. 02078-06
44. Hamilton BJ, Nichols RC, Tsukamoto H, Boado RJ, Pardridge WM, Rigby WF. hnRNP A2 and hnRNP L bind the 30UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun 1999; 261: 646-51; PMID: 10441480; http://dx. doi. org/10. 1006/bbrc. 1999. 1040
45. Jafarifar F, Yao P, Eswarappa SM, Fox PL. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J 2011; 30: 1324-34; PMID: 21343907; http://dx. doi. org/10. 1038/emboj. 2011. 38
46. Kim HH, Abdelmohsen K, Gorospe M. Regulation of HuR by DNA Damage Response Kinases. J Nucleic Acids 2010; 8 p. 981487; PMID: 20798862.
47. Yu C, Xin W, Zhen J, Liu Y, Javed A, Wang R, Wan Q. Human antigen R mediated post-transcriptional regulation of epithelial-mesenchymal transition related genes in diabetic nephropathy. J Diabetes 2014; 7: 562-72; doi: 10. 1111/1753-0407. 12220.
48. Scheiba RM, de Opakua AI, Díaz-Quintana A, Cruz-Gallardo I, Martínez-Cruz LA, Martínez-Chantar ML, Blanco FJ, Díaz-Moreno I. The C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets. RNA Biol 2014; 11: 1250-61; PMID: 25584704
49. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 2000; 20: 760-9; PMID: 10629032; http://dx. doi. org/ 10. 1128/MCB. 20. 3. 760-769. 2000
50. Burkhart RA, Pineda DM, Chand SN, Romeo C, Londin ER, Karoly ED, Cozzitorto JA, Rigoutsos I, Yeo CJ, Brody JR, et al. HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer. RNA Biol 2013; 10: 1312-23; PMID: 23807417; http://dx. doi. org/10. 4161/rna. 25274